Pennsylvania Bio collaborates with Italian biotech association

30 June 2011

The USA’s Pennsylvania Bio, the only state-wide trade association representing Pennsylvania’s entire bioscience industry, and Assobiotec, the Italian association for the development of biotechnology, have set up BioBridge, a collaborative relationship to develop, evolve and sustain the life sciences industry relationship between Italy and Pennsylvania.

The joint collaboration was formalized this week by the signing of a Memorandum of Understanding (MOU) at a ceremony at the Italian Embassy in Washington DC. This collaborative effort provides an opportunity for present and future partnerships between the USA and Italy, and will unite their respective life sciences communities and tremendous bases of scientific talent.

“Italian scientists have contributed significantly to advancing the Life Sciences industry globally,” said Christopher Molineaux, resident of Pennsylvania Bio, adding: “Combined with the scientific talent in Pennsylvania’s life sciences companies and research institutions, this MOU provides the foundation for a strong and mutually beneficial collaboration between Pennsylvania and Italian life sciences organizations.”

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Biotechnology